Types of Alternative Medicine Used by Patients with Breast, Colon, or Prostate Cancer: Predictors, Motives, and Costs

Patterson, Ruth E.; Neuhouser, Marian L.; Hedderson, Monique M.; Schwartz, Stephen M.; Standish, Leanna J.; Bowen, Deborah J.; Marshall, Lynn M.

doi:10.1089/107555302760253676

Cited by 189 publications

(170 citation statements)

References 15 publications

Supporting

Mentioning

150

Contrasting

Order By: Relevance

“…The use of alternative medicine and the treatment delay caused by that has been well-documented in the past [9,22,23]. In the developed countries, the use of alternative medicine is primarily attributable to the psychological distress over potential, often mutilating treatments [24,25].…”

Section: Discussionmentioning

confidence: 99%

Treatment Delay in Oral and Oropharyngeal Cancer in Our Population: The Role of Socio-Economic Factors and Health-Seeking Behaviour

Agarwal

Sethi

Sareen

et al. 2011

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

The objective is to assess the role of socioeconomic factors and health-seeking behavior in treatment delay in oral and oropharyngeal cancer in our population. This article adapts-design: prospective study and setting: tertiary care centre. We studied 153 patients with oral and oropharyngeal squamous cell carcinoma who were managed in the department of otolaryngology and head and neck surgery between January 2006 and December 2007. There were 127 male patients (83%) and 26 females (17%) with ages ranging from 22 years to 70 years. Fifty-nine patients (39%) presented to us with early stage disease (i.e. stage I and II), whereas, 94 patients (61%) presented with late stage disease (i.e. stage III and IV). Of the 59 patients presenting with early stage disease, 20 were illiterate and 39 literate with 28 patients (47%) belonging to low socio-economic status and 32 patients (54%) having an access to primary health centre (PHC). Of the 94 patients presenting with late stage disease, 53 were illiterate and 41 literate with 58 patients (62%) belonging to low socio-economic status and 38 patients (40%) having an access to primary health centre. Literacy, socio-economic status, access to primary health centre and health-seeking behavior of our population has a significant association with the stage of presentation of patients with oral and oropharyngeal cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Treatment Delay in Oral and Oropharyngeal Cancer in Our Population: The Role of Socio-Economic Factors and Health-Seeking Behaviour

Agarwal

Sethi

Sareen

et al. 2011

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…It has been observed to be higher in breast and prostate cancer populations than in populations with other cancer diagnoses 20,23 . The heightened interest in CAM in these populations may be a consequence of the proactive nature of these patient groups with regard to advocacy and self-care (that is, support-group membership).…”

Section: 11mentioning

confidence: 99%

Patient Decision-Making about Complementary and Alternative Medicine in Cancer Management: Context and Process

2008

View full text Add to dashboard Cite

ObjectiveIn this paper, we set out to describe the personal and social contexts of treatment decisions made by cancer patients concerning complementary and alternative medicine (CAM) and also the process through which cancer patients reach CAM decisions throughout the cancer trajectory. MethodsWe selected and reviewed a variety of CAM decisionmaking models published in the past 10 years within the Canadian health literature. ResultsThe CAM decision-making process is influenced by a variety of sociodemographic, disease-related, psychological, and social factors. We reviewed four main phases of the CAM decision-making process:• Taking stock of treatment options • Gathering and evaluating CAM information • Making CAM decisions • Revisiting the CAM decision Immediately following diagnosis, cancer patients become interested in taking stock of the full spectrum of conventional and CAM treatment options that may enhance the effectiveness of their treatment and mediate potential side effects. Information about CAM is then gathered from numerous information sources that vary in terms of credibility and scientific legitimacy, and is evaluated. When making a decision regarding CAM options, patients attempt to make sense of the diverse information obtained, while acknowledging their beliefs and values. The CAM decision is often revisited at key milestones, such as the end of conventional treatment and when additional information about disease, prognosis, and treatment is obtained. ConclusionsThe CAM decision-making process is a dynamic and iterative process that is influenced by a complex array of personal and social factors. Oncology health professionals need to be prepared to offer decision support related to CAM throughout the cancer trajectory.

show abstract

“…22,24,28,29,34,36,37,39,40,50,51,54,56,[58][59][60]62 The remaining studies collected data from broader study populations and reported the prevalence of CAM use for subgroups including men with prostate cancer. 23,[25][26][27][30][31][32][33]35,38,[41][42][43][44][45][46][47][48][49]52,53,55,57,61,63 The characteristics of all 42 included studies are summarised in Table 2 …”

Section: Study Selection and Characteristicsmentioning

confidence: 99%

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies

Bishop

Rea

Lewith

et al. 2010

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality assessment. Six electronic databases were searched using pre-defined terms. Detailed information was extracted systematically from each relevant article. Study reporting quality was assessed using a quality assessment tool, which demonstrated acceptable inter-rater reliability and produces a percentage score. In all, 42 studies are reviewed. All were published in English between 1999 and 2009; 60% were conducted in the United States. The reporting quality was mixed (median score ¼ 66%, range 23-94%). Significant heterogeneity precluded formal meta-analysis. In all, 39 studies covering 11 736 men reported overall prevalence of CAM use; this ranged from 8 to 90% (median ¼ 30%). In all, 10 studies reported prevalence of CAM use specifically for cancer care; this ranged from 8 to 50% (median ¼ 30%). Some evidence suggested CAM use is more common in men with higher education/incomes and more severe disease. The prevalence of CAM use among men with prostate cancer varies greatly across studies. Future studies should use standardised and validated data collection techniques to reduce bias and enhance comparability.

show abstract

Types of Alternative Medicine Used by Patients with Breast, Colon, or Prostate Cancer: Predictors, Motives, and Costs

Cited by 189 publications

References 15 publications

Treatment Delay in Oral and Oropharyngeal Cancer in Our Population: The Role of Socio-Economic Factors and Health-Seeking Behaviour

Treatment Delay in Oral and Oropharyngeal Cancer in Our Population: The Role of Socio-Economic Factors and Health-Seeking Behaviour

Patient Decision-Making about Complementary and Alternative Medicine in Cancer Management: Context and Process

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies

Contact Info

Product

Resources

About